← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1996Last known activity
Jun 20, 2024
Timeline
1990s
- Jan 1, 1994
Office of Dietary Supplements (ODS)— Founded
Drugs by trial phase (54 distinct, 48 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (23 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Amyotrophic Lateral Sclerosis
- Anxiety Disorders
- Arthritis
- Arthritis, Experimental
- Arthritis, Rheumatoid
- Asthma
- Atherosclerosis
- Bone Diseases, Metabolic
- Bone Resorption
- Cardiovascular Diseases
- Carotid Artery Diseases
- Cataract
- Common Cold
- Depression
- Depressive Disorder
- Eye Diseases
- Heart Diseases
- Hepatitis
- Hepatitis A
- Hepatitis, Alcoholic
- Hepatitis C
- Hepatitis C, Chronic
- HIV Infections
- Hot Flashes
- Hypercholesterolemia
- Hyperlipidemias
- Hypertension
- Infections
- Inflammation
- Insulin Resistance
- Kidney Diseases
- Macular Degeneration
- Mood Disorders
- Motor Neuron Disease
- Obesity
- Osteoarthritis
- Osteoarthritis, Knee
- Osteoporosis
- Overweight
- Parasomnias
- Parkinson Disease
- Renal Insufficiency, Chronic
- Respiratory Sounds
- Sclerosis
- Sleep Wake Disorders
- Urinary Tract Infections
Recent trials (48)
- NCT06692933CollaboratorEarly Phase 1Jun 20, 2024
- NCT05157672CollaboratorEarly Phase 1Nov 16, 2021
- NCT02962128CollaboratorN/ANov 29, 2016
- NCT02123121CollaboratorPhase 2Sep 1, 2015
- NCT02337231CollaboratorN/AJun 24, 2014
- NCT02088203CollaboratorPhase 1Feb 1, 2014
- NCT02015611CollaboratorN/ADec 1, 2013
- NCT01942694CollaboratorN/AOct 1, 2013
- NCT01797302CollaboratorN/AAug 1, 2013
- NCT01601847CollaboratorPhase 4Jan 1, 2013
- NCT01723696CollaboratorPhase 2/Phase 3Dec 1, 2012
- NCT01632761CollaboratorN/ANov 1, 2012
- NCT01537809CollaboratorN/AJun 1, 2011
- NCT01169259CollaboratorPhase 3Jul 1, 2010
- NCT01027143CollaboratorPhase 2/Phase 3Jul 1, 2010
Details
- Founded
- Bethesda, MD, US Jan 1, 1994
- Last known activity
- Jun 20, 2024